[SRNE] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
25-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -41.42%
YoY- -130.31%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 84 142 134 122 135 217 110 -16.44%
PBT -3,356 -4,737 -2,522 -3,236 -1,241 -943 -906 139.21%
Tax 2 2 2 -3,090 4 4 3 -23.66%
NP -3,356 -4,737 -2,522 -1,755 -1,241 -943 -906 139.21%
Tax Rate - - - - - - - -
Total Cost 3,440 4,878 2,656 1,877 1,376 1,160 1,016 125.31%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin -4,005.73 -3,345.11 -1,881.46 -1,438.58 -922.81 -434.35 -822.64 187.00%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS -0.24 -0.35 -0.20 -0.14 -0.10 -0.08 -0.09 92.18%
EPS Diluted -0.24 -0.35 -0.20 -0.14 -0.10 -0.08 -0.09 92.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.